Who invested in Cambrian Biopharma

One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Raised 4 months agoValuation: $1.8B, Mar 2026

Funding summaryUpdated 26 Oct 2026

$124Mraised across 1 round since 2026, from 1 source

Latest round: Venture, $124MJul 2026
Investors: 5

See who backed them

The rounds

Jul 2026
Venture$124M
Source recordedSEC filing: $124M sold

Founders and team

From Cambrian Biopharma's own website: 1 founder, 14 on the team.

Christian AngermayerChairman, Co-Founder, Board Director

Catherine ChungExecutive Assistant to the CEO
Bill DeVaulChief Legal Officer
Erik SchneiderVP, Strategy & Business Development
Hardik RanaHead of CMC
Jessica AinscoughVP, Clinical Operations
Margaret KurtzVP, People and Culture
Ying LiVP, Operations
Alec ElliottClinical Trial Associate
Brenton L. SaundersBoard Director
Chris BakerSenior Clinical Trial Manager
Claudia ParejaDigital and Social Media Manager
Maryanna SaenkoBoard Director
Paul FarrBoard Director
Ryan WhiteSenior IT Manager

Everyone who backed them

Alumni VenturesVC firm1round

FJ LabsVC firm1round

Catalio Capital ManagementVC firm1round

Galaxy DigitalPrivate equity1round

Future VenturesVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Cambrian Biopharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.